Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

EAST SIDE CLINICAL LABORATORY, INC.

NPI: 1861404121 · EAST PROVIDENCE, RI 02914 · Clinical Medical Laboratory · NPI assigned 08/13/2006

$48.64M
Total Medicaid Paid
3,627,098
Total Claims
2,803,958
Beneficiaries
295
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGREENBERG, ALAN (PRESIDENT)
NPI Enumeration Date08/13/2006

Related Entities

Other providers sharing the same authorized official: GREENBERG, ALAN

ProviderCityStateTotal Paid
SUNRISE MEDICAL LABORATORIES, INC. HICKSVILLE NY $101.48M
INNOVATION OPTICS ROSELLE PARK NJ $269K
INNOVATIVE EYEWEAR SHORT HILLS NJ $7K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 629,095 $7.41M
2019 562,799 $5.53M
2020 411,481 $5.30M
2021 556,813 $8.46M
2022 531,695 $8.45M
2023 498,831 $7.10M
2024 436,384 $6.40M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 80,817 55,619 $5.66M
80050 General health panel 105,818 91,132 $5.07M
80061 Lipid panel 198,951 172,762 $2.74M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 87,172 75,656 $2.38M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 35,546 30,295 $1.58M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 237,969 174,398 $1.38M
80053 Comprehensive metabolic panel 144,149 118,514 $1.20M
83036 Hemoglobin; glycosylated (A1C) 136,915 119,255 $1.12M
84443 Thyroid stimulating hormone (TSH) 85,287 73,837 $1.10M
36415 Collection of venous blood by venipuncture 303,829 187,573 $1.08M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 26,341 22,710 $1.03M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 26,120 22,041 $1.02M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 50,145 35,612 $871K
86480 16,366 14,952 $768K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 16,903 9,272 $742K
86803 50,902 42,183 $686K
86003 7,512 6,008 $671K
82607 47,442 41,751 $637K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 16,483 9,316 $581K
80048 Basic metabolic panel (calcium, ionized) 112,370 76,632 $564K
82728 38,051 32,957 $515K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3,613 3,478 $502K
87522 Neg quan hep c or qual rna 10,382 8,163 $489K
87086 Culture, bacterial; quantitative colony count, urine 89,610 75,429 $480K
84439 48,730 43,401 $449K
85027 63,236 53,144 $371K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 16,713 15,993 $348K
87902 1,684 1,154 $344K
83013 4,513 3,716 $344K
84403 11,077 9,776 $308K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 103,701 38,178 $298K
84481 33,511 30,129 $292K
80076 46,226 36,768 $289K
81001 86,846 73,542 $281K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,716 5,427 $280K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3,485 2,800 $265K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3,503 3,083 $264K
82043 39,902 35,496 $263K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,743 1,651 $261K
86706 22,557 17,473 $238K
82652 5,507 5,025 $236K
86780 21,243 18,971 $233K
84153 13,949 12,060 $233K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 7,410 6,607 $227K
82570 43,690 38,280 $209K
80074 4,181 3,736 $205K
83550 25,246 21,989 $201K
86618 9,905 9,224 $194K
82746 20,649 18,273 $189K
83970 5,666 4,749 $188K
83516 8,032 7,177 $187K
87186 26,201 22,062 $177K
87070 18,288 16,248 $172K
87340 15,604 12,814 $172K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 906 831 $170K
83880 10,858 7,384 $161K
88112 2,284 1,226 $159K
86038 11,850 10,603 $159K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 5,025 4,447 $147K
84402 5,878 5,216 $139K
84146 6,672 5,826 $134K
86762 8,245 7,087 $128K
86704 10,452 8,569 $127K
83540 17,816 16,110 $123K
86617 3,529 3,115 $123K
86787 8,377 7,218 $120K
86769 2,992 2,838 $119K
84460 24,649 20,723 $117K
87338 5,899 5,261 $116K
83001 5,582 5,042 $115K
86140 25,351 18,271 $112K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3,695 3,431 $108K
84702 6,090 4,893 $106K
83735 24,254 17,805 $105K
86665 2,932 2,664 $105K
84450 21,752 18,685 $104K
87088 16,948 13,741 $104K
85652 34,007 26,743 $101K
82670 3,409 3,141 $101K
86317 1,462 1,171 $101K
86765 7,294 6,250 $101K
86735 7,218 6,186 $100K
86708 9,470 6,563 $96K
86696 4,213 3,814 $94K
85610 52,862 19,375 $92K
87467 5,109 4,956 $92K
82274 6,786 4,921 $89K
82550 14,201 12,093 $87K
86709 5,997 5,147 $87K
82784 5,147 4,697 $80K
83002 3,892 3,521 $78K
83690 10,640 9,445 $77K
86200 3,440 3,141 $73K
87510 3,014 2,581 $73K
87480 3,007 2,580 $72K
84207 2,491 2,202 $71K
87660 2,857 2,446 $70K
82565 16,971 13,541 $69K
83721 11,395 9,759 $68K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 5,127 4,368 $66K
87209 3,084 2,289 $64K
84154 3,260 2,898 $61K
82150 8,530 7,507 $58K
85007 18,590 14,524 $57K
87077 8,950 7,988 $56K
84445 913 807 $53K
87427 2,154 1,825 $53K
83020 3,523 2,844 $51K
86695 3,701 3,291 $50K
82785 2,841 2,699 $47K
80164 6,360 4,711 $46K
80051 8,486 6,794 $46K
82248 11,485 9,564 $46K
86376 2,873 2,548 $45K
86664 2,876 2,616 $45K
84550 11,237 9,630 $44K
82627 1,791 1,593 $44K
87536 481 442 $42K
84480 3,270 2,845 $42K
84484 3,152 2,746 $41K
82947 10,668 8,813 $40K
84252 1,632 1,520 $40K
86663 2,889 2,643 $40K
84134 6,346 4,104 $39K
82140 5,766 3,566 $39K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 91,650 42,782 $39K
87046 2,182 1,850 $39K
86705 2,587 2,501 $37K
84100 9,819 6,842 $36K
86430 5,517 4,907 $35K
85379 6,866 4,272 $35K
ATP14 5,515 5,248 $34K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 213 164 $34K
84703 3,952 3,509 $34K
84436 6,735 5,439 $33K
86694 2,094 1,808 $33K
83525 2,505 2,276 $32K
87481 386 330 $31K
82105 2,228 1,878 $31K
84520 10,768 8,546 $31K
82465 5,955 5,301 $31K
87625 1,233 1,046 $30K
86256 1,227 1,005 $30K
85018 12,675 10,939 $30K
86666 818 718 $28K
84165 2,339 2,034 $28K
84425 3,548 3,050 $28K
86160 1,069 948 $28K
82533 1,560 1,398 $26K
87045 2,804 2,511 $26K
82977 3,702 3,256 $26K
84075 5,079 4,316 $25K
84466 2,124 1,677 $25K
81003 10,064 9,500 $24K
82024 598 528 $24K
86235 1,099 894 $24K
86141 2,017 1,831 $23K
87529 327 306 $23K
87177 3,051 2,277 $23K
85730 3,772 3,074 $23K
86225 1,454 1,336 $23K
84590 1,793 1,635 $23K
87511 695 640 $22K
86800 1,364 1,190 $22K
84144 1,039 948 $22K
80178 3,717 3,089 $21K
83921 1,210 1,039 $21K
82103 1,414 1,242 $21K
87205 4,892 3,768 $20K
83993 777 719 $19K
83090 682 613 $18K
81000 4,807 4,120 $18K
83520 1,206 1,054 $18K
84156 2,998 2,467 $17K
82247 3,519 2,918 $17K
80069 2,162 1,822 $17K
83615 3,498 2,604 $17K
87517 369 329 $17K
82955 2,201 1,876 $17K
85045 3,513 3,071 $17K
84270 702 611 $17K
86677 676 526 $16K
87469 303 296 $16K
83498 459 441 $16K
87484 267 261 $15K
82040 5,757 4,653 $15K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 58,877 30,639 $15K
81025 2,132 1,961 $15K
80159 1,127 738 $14K
86431 2,164 2,102 $14K
80177 2,208 1,552 $14K
84132 4,333 2,799 $13K
86334 603 521 $12K
82310 2,640 2,062 $12K
86901 2,130 1,818 $12K
86308 2,023 1,804 $12K
87255 241 213 $11K
85014 6,013 4,645 $11K
84145 1,632 1,030 $11K
83655 1,542 1,380 $11K
82553 1,038 927 $11K
87634 254 237 $11K
82747 680 615 $10K
83519 615 490 $10K
84181 384 313 $9K
ATP07 1,277 1,247 $9K
86039 636 609 $9K
88304 233 148 $9K
84155 2,514 2,322 $9K
86900 2,035 1,729 $9K
86850 1,540 1,329 $9K
87081 1,589 1,226 $8K
87324 581 439 $8K
80202 970 213 $8K
87468 298 292 $8K
82390 715 593 $8K
87449 722 525 $8K
84305 324 314 $8K
86753 388 359 $8K
84479 1,337 1,024 $8K
87476 162 153 $7K
84630 572 526 $7K
87478 252 248 $7K
80047 787 542 $7K
87328 326 275 $7K
83718 717 657 $7K
82330 1,111 961 $6K
ATP08 1,210 1,129 $6K
86255 330 285 $5K
87400 350 336 $5K
86592 1,195 1,053 $5K
84681 225 200 $5K
83883 332 193 $4K
88312 85 50 $4K
84478 863 512 $4K
82950 935 797 $4K
87073 423 309 $4K
ATP15 694 617 $4K
ATP03 580 578 $4K
83010 368 199 $3K
82172 161 94 $3K
84166 147 96 $3K
80156 287 204 $3K
82552 211 168 $3K
81015 769 724 $3K
ATP17 768 737 $2K
80185 273 151 $2K
82270 673 577 $2K
85245 66 65 $2K
86147 27 25 $2K
84432 112 82 $2K
82088 30 29 $2K
82525 117 106 $2K
82378 172 113 $2K
86747 106 102 $2K
85246 52 52 $1K
85240 62 62 $1K
86341 37 33 $1K
87040 187 84 $1K
82653 38 38 $1K
82626 43 41 $994.69
82157 25 25 $965.18
84080 63 60 $880.71
ATP16 116 112 $838.53
84295 191 153 $835.42
86060 98 95 $832.66
88311 80 47 $785.23
85048 262 245 $780.55
84244 29 28 $762.12
86645 51 49 $715.68
82951 39 30 $608.29
82671 15 15 $474.12
86682 26 25 $427.16
82397 12 12 $422.12
ATP11 57 57 $382.62
87350 29 25 $364.32
83605 27 26 $342.25
86162 14 13 $313.43
83835 15 13 $292.65
86644 17 17 $283.81
86707 12 12 $244.40
83695 12 12 $220.85
ATP18 97 97 $208.43
82104 12 12 $207.92
86215 12 12 $176.22
85049 34 24 $164.66
84300 24 24 $130.92
87101 12 12 $119.14
85660 12 12 $68.23
83935 18 12 $57.70
ATP13 34 34 $43.56
ATP19 30 30 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 12 12 $0.00
U00O3 58 18 $0.00
80301 41 16 $0.00